(Q36662494)

15 August 2017

1 reference

title

Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases (English)

1 reference

15 August 2017

K Henriksen

1

1 reference

15 August 2017

L B Tanko

2

1 reference

15 August 2017

P Qvist

3

1 reference

15 August 2017

P D Delmas

4

1 reference

15 August 2017

C Christiansen

5

1 reference

15 August 2017

M A Karsdal

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

24 November 2006

1 reference

Osteoporosis International

15 August 2017

1 reference

15 August 2017

18

1 reference

15 August 2017

5

1 reference

15 August 2017

681-685

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-006-0286-8

15 August 2017

0 references

cites work

Bone cell populations and histomorphometric correlates to function

1 reference

12 December 2020

Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts

1 reference

12 December 2020

The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities

1 reference

12 December 2020

Therapeutic approaches to bone diseases

1 reference

12 December 2020

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group

1 reference

12 December 2020

Estrogen and bone metabolism

1 reference

12 December 2020

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment

1 reference

12 December 2020

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

1 reference

12 December 2020

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

1 reference

12 December 2020

The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation

1 reference

12 December 2020

Osteoprotegerin as a potential therapy for osteoporosis

1 reference

12 December 2020

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

1 reference

12 December 2020

Is the paradigm shifting?

1 reference

12 December 2020

Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide

1 reference

12 December 2020

Biochemical markers of bone turnover.

1 reference

12 December 2020

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

12 December 2020

Osteoclast-derived activity in the coupling of bone formation to resorption.

1 reference

12 December 2020

Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis.

1 reference

12 December 2020

Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression

1 reference

12 December 2020

Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?

1 reference

12 December 2020

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

1 reference

12 December 2020

Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone

1 reference

12 December 2020

Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior

1 reference

12 December 2020

Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II

1 reference

12 December 2020

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

12 December 2020

Mechanism of action of bisphosphonates

1 reference

12 December 2020

Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src

1 reference

12 December 2020

Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

1 reference

12 December 2020

Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption

1 reference

12 December 2020

Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.

1 reference

12 December 2020

Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).

1 reference

12 December 2020

Hormones in the coupling of bone resorption and formation

1 reference

12 December 2020

Denosumab in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

1 reference

12 December 2020

Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women

1 reference

12 December 2020

Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices

1 reference

12 December 2020

Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.

1 reference

12 December 2020

Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

1 reference

12 December 2020

Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover

1 reference

12 December 2020

Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.

1 reference

12 December 2020

10.1007/S00198-006-0286-8

Identifiers

DOI

1 reference

15 August 2017

1 reference